Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse:A 30-month follow-up study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  González Blanch, César ^a   Gleeson, John F ^b   Koval, Peter ^b,c   Cotton, Sue M ^d,e   McGorry, Patrick D ^d,e   Alvarez Jimenez, Mario ^d,e  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT; CANNABIS;

ADOLESCENT; ADULT; AGE; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; DSM-IV; EARLY INTERVENTION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GENDER; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PSYCHOSIS; REFERENCE VALUE; REMISSION; SENSITIVITY AND SPECIFICITY; SOCIAL INTERACTION; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SOCIAL ADAPTATION; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; CANNABIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHOTIC DISORDERS; SOCIAL SKILLS; YOUNG ADULT;

EID: 84928882689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122404     Document Type: Article

References (45)

1. UNODC (2013) World Drug Report 2013 (United Nations publication, Sales No. E.13.XI.6). Available: http://www.unodc.org/unodc/secured/wdr/wdr2013/World-Drug-Report-2013.pdf
2. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511-2518. PMID: 2232018
3. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36: 1115-1130. doi: 10.1093/schbul/sbp031 PMID: 19386576
4. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328. PMID: 17662880
5. Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, et al. (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 193: 357-363. doi: 10.1192/ bjp.bp.107.046375 PMID: 18978312
6. Clausen L, Hjorthoj CR, Thorup A, Jeppesen P, Petersen L, Bertelsen M, et al. (2014) Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychol Med 44:117-26. doi: 10.1017/ S0033291713000433 PMID: 23590927
7. Bahorik AL, Newhill CE, Eack SM (2013) Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 108: 1259-1269. doi: 10.1111/add.12153 PMID: 23432626
8. Faber G, Smid HG, Van Gool AR, Wunderink L, van den Bosch RJ, Wiersma D (2012) Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. J Clin Psychiatry 73: 632-638. doi: 10.4088/JCP.11m07069 PMID: 22394457
9. Pencer A, Addington J, Addington D (2005) Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res 133: 35-43. PMID: 15698675
10. Addington J, Addington D (2007) Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 115: 304-309. PMID: 17355521
11. Foti DJ, Kotov R, Guey LT, Bromet EJ (2010) Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. AJ Psychiatry 167: 987-993.
12. Gonzalez-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibáñez B, et al. (2011) Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull 37: 631-639. doi: 10.1093/schbul/sbp126 PMID: 19915168
13. Barrowclough C, Emsley R, Eisner E, Beardmore R, Wykes T (2013) Does change in cannabis use in established psychosis affect clinical outcome? Schizophr Bull 39: 339-348. doi: 10.1093/schbul/ sbr152 PMID: 22037770
14. Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M (2012) Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. European Psychiatry 27: 463-469. doi: 10.1016/j.eurpsy.2011.03.001 PMID: 21616646
15. Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Crisp K, Newman B, et al. (2010) Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis. J Clin Psychiatry 71: 475-483. doi: 10.4088/JCP.08m04672yel PMID: 20021994
16. Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al. (2009) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry 70: 477-486. PMID: 19323964
17. Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al. (2013) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month fol-low-up. Schizophr Bull 39: 436-448. doi: 10.1093/schbul/sbr165 PMID: 22130905
18. Alvarez-Jimenez M, Gleeson JF, Cotton S, Wade D, Gee D, Pearce T, et al. (2009) Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis. Can J Psychiatry 54: 710-718. PMID: 19835678
19. APA APA (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Press.
20. Lukoff D, Liberman RP, Nuechterlein KH (1986) Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 12: 578-602. PMID: 3810065
21. First M, Spitzer R, Williams J, Gibbon M (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) User's guide and Interview. Washington, DC: American Psychiatric Press.
22. Montgomery SM (1979) Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol 3: 429-433. PMID: 400999
23. Andreasen NC (1984) Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa.
24. Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8: 470-484. PMID: 7134891
25. Ginsberg J (2003) Wechsler test of adult reading. Applied Neuropsychology: 182-184.
26. Goldman HH, Skodol AE, Lave TR (1992) Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 149: 1148-1156. PMID: 1386964
27. Cassidy CM, Norman R, Manchanda R, Schmitz N, Malla A (2010) Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. Schizophr Bull 36: 1001-1008. doi: 10.1093/schbul/sbp007 PMID: 19321629
28. WHO ASSIST Working Group (2002) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 97: 1183-1194. PMID: 12199834
29. Newcombe DA, Humeniuk RE, Ali R (2005) Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev 24: 217-226. PMID: 16096125
30. Hides L, Cotton SM, Berger G, Gleeson J, O'Donnell C, Proffitt T, et al. (2009) The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis. Addict Behav 34: 821-825. doi: 10.1016/j.addbeh.2009.03.001 PMID: 19324499
31. Gonzalez-Blanch C, Gleeson JF, Cotton SM, Crisp K, McGorry PD, Alvarez-Jimenez M (2015) Longitudinal relationship between expressed emotion and cannabis misuse in young people with first-episode psychosis. European Psychiatry 30: 20-25. doi: 10.1016/j.eurpsy.2014.07.002 PMID: 25174270
32. Portney LG, Watkins MP (2000) Foundations of clinical research: Applications to practice. NJ: Pren-tice-Hall, Upper Saddle River.
33. Bolger N, Laurenceau J-P (2013) Intensive longitudinal methods: An introduction to diary and experience sampling research. New York: Guilford.
34. Rey JM, Martin A, Krabman P (2004) Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. J Am Acad Child Adolesc Psychiatry 43: 1194-1205. PMID: 15381886
35. Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry 172: 53-59. PMID: 9534833
36. Hjorthoj CR, Baker A, Fohlmann A, Nordentoft M (2014) Intervention efficacy in trials targeting cannabis use disorders in patients with comorbid psychosis systematic review and meta-analysis. Curr Pharm Des 20: 2205-2211. PMID: 23829367
37. Wisdom JP, Manuel JI, Drake RE (2011) Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment. Psychiatr Serv 62: 1007-1012. doi: 10.1176/ appi.ps.62.9.1007 PMID: 21885577
38. Edwards J, Elkins K, Hinton M, Harrigan SM, Donovan K, Athanasopoulos O, et al. (2006) Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand 114: 109-117. PMID: 16836598
39. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y (2006) A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 63: 426-432. PMID: 16585472
40. González-Blanch C, Pérez-Iglesias R, Pardo-Garcia G, Rodríguez-Sánchez JM, Martínez-García O, Vázquez-Barquero JL, et al. (2010) Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia. Psychol Med 40: 935-944. doi: 10.1017/S0033291709991267 PMID: 19751542
41. Rabin RA, Zakzanis KK, George TP (2011) The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res 128: 111-116. doi: 10.1016/j.schres.2011.02.017 PMID: 21420282
42. Yucel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, et al. (2012) The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull 38: 316-330. doi: 10.1093/schbul/sbq079 PMID: 20660494
43. Lynskey M, HallW(2000) The effects of adolescent cannabis use on educational attainment: a review. Addiction 95: 1621-1630. PMID: 11219366
44. Nakagami E, Xie B, Hoe M, Brekke JS (2008) Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects. Schizophr Res 105: 95-104. doi: 10.1016/j.schres.2008.06.015 PMID: 18715756
45. Hoenig JM, Heisey DM (2001) The pervasive fallacy of power calculations for data analysis. Am Stat 55: 19-24.